Primary Breast Cancer AR+ve TNBN
1 clinical trials · Condition
◉ Watch Primary Breast Cancer AR+ve TNBN
| Record | Firm | Date |
|---|---|---|
| Short-term Preoperative Treatment With Enzalutamide, Alone or in Combination With Exemestane in Primary Breast Cancer (NCT02676986) | Queen Mary University of London | 2015-08-10 |
Track Primary Breast Cancer AR+ve TNBN automatically
Every clearance here is in the API, with alerts when new ones post.